Vedolizumab vs. Anti-TNF Agents in Biologic-naive UC Patients Vedolizumab vs. Anti-TNF Agents in Biologic-naive UC Patients
This study investigated the effectiveness of vedolizumab versus anti-TNF therapy in biologic-naive patients with ulcerative colitis at the end of induction therapy and during maintenance treatment.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Drugs & Pharmacology | Gastroenterology | Health | Inflammatory Bowel Disease | Study | Ulcerative Colitis